Clinical Trials

Urinary Bladder Neoplasms

NCT04241185 2026-05-01

MK-3475-992

520 enrolled

Urinary Bladder Neoplasms

NCT06960577 2026-04-23

Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)

Phase 3 Recruiting

150 enrolled

Urinary Bladder Neoplasms

NCT05911295 2026-04-20

Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2

412 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT03661320 2026-04-15

A Study to Compare Chemotherapy Alone Versus Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Therapy After Surgery With Nivolumab or Nivolumab and BMS-986205 in Participants With Muscle Invasive Bladder Cancer

855 enrolled

Urinary Bladder Neoplasms

NCT03732677 2026-03-13

NIAGARA

1,063 enrolled 15 charts 1 FDA

Urinary Bladder Neoplasms

NCT04700124 2026-02-05

KEYNOTE-B15

808 enrolled

Parkinson Disease 4, Autosomal Dominant Lewy Body, Urinary Bladder Neoplasms

NCT04574960 2025-07-20

NAUTICAL

Phase 3 Recruiting

14 enrolled

Urinary Bladder Neoplasms

NCT02807636 2025-02-24

IMvigor130

1,213 enrolled 35 charts

Phase 3 Not yet recruiting

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT06364904 2025-02-21

A Clinical Trail to Determine the Safety and Efficacy of the Combination of Tislelizumab With Cisplatin and Gemcitabine, With or Without Trilaciclib for Patients With Untreated Unresectable and Metastatic Urothelial Carcinoma.

210 enrolled

Urinary Bladder Neoplasms

NCT02695771 2023-04-21

BIC

101 enrolled 11 charts

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT00445601 2020-01-18

S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer

406 enrolled 16 charts

Urinary Bladder Neoplasms

NCT00028756 2016-08-02

Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium

285 enrolled

Urinary Bladder Neoplasms

NCT00014534 2016-07-14

Combination Chemotherapy in Treating Patients With Bladder Cancer

42 enrolled

Urinary Bladder Neoplasms

NCT00625664 2016-05-05

CILAB

337 enrolled

Urinary Bladder Neoplasms, Neoplasms

NCT02074189 2014-02-28

Adjuvant Chemotherapy Following Radical Cystectomy to Treat Locally Advanced Bladder Cancer

Phase 3 Unknown

200 enrolled

Urinary Bladder Neoplasms

NCT00054626 2013-12-18

Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder Cancer

Phase 3 Unknown

700 enrolled

Urinary Bladder Neoplasms

NCT00022191 2013-06-12

Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer

608 enrolled

Urinary Bladder Neoplasms, Urethral Neoplasms

NCT00237575 2012-05-23

Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin & Gemcitabine for Urothelial Cancer

Phase 3 Terminated

100 enrolled

Urinary Bladder Neoplasms, Neoplasm Metastasis

NCT00191477 2009-10-28

Instillation of Gemcitabine in Patients With Superficial Bladder Cancer

Phase 3 Terminated

355 enrolled 15 charts

Urinary Bladder Neoplasms

NCT00146276 2006-09-27

Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer

Phase 3 Unknown

178 enrolled